NeuroTherapia
Manufacturing · Ohio, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1500 Chagrin River Rd, Gates Mills, Ohio...Phone Number
(440) 228-4089Website
www.neurotherapia.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About NeuroTherapia
Founded in 2015 and headquartered in Gates Mills, Ohio, NeuroTherapia biotech company developing a novel small molecule for the treatment of neurodegenerative disorders. NTRX-07 is a small orally-available molecule that targets receptors that are known to be increased in diseases including Alzheimer's disease (AD), ALS, MS and chronic pain syndromes.Explore more
NeuroTherapia Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeuroTherapia your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if NeuroTherapia is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at NeuroTherapia
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once NeuroTherapia has new funding data
Product Launch: Get notified when NeuroTherapia launches new products
Check if NeuroTherapia has recently received funding, and reach out quickly before it becomes old news!
Click to see if NeuroTherapia had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
NeuroTherapia, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on NeuroTherapia recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to NeuroTherapia
Compare insights from companies similar to NeuroTherapia, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NeuroTherapia is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NeuroTherapia is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NeuroTherapia.
NeuroTherapia financials insights
Gather financial insights about NeuroTherapia, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series B
$12.3M
NeuroTherapia Tech Stack
A closer look at the technologies used by NeuroTherapia
See more technologies
NeuroTherapia News & Media
NeuroTherapia announces completion of its Phase 2a Trial of a novel treatment for Alzheimer's Disease
Trial Designed to Demonstrate Target Engagement, Safety, and Pharmacokinetics CLEVELAND, April 7, 2026 /PRNewswire/ -- NeuroTherapia, Inc., a clinical-stage company focused on developing oral therapies for neurodegenerative diseases, has completed its Phase 2a clinical trial in...NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
Investment will allow NeuroTherapia to continue the development of an orally available treatment for Alzheimer's disease. CLEVELAND, Aug. 6, 2024 /PRNewswire/ -- NeuroTherapia, Inc., a clinical-stage company and Cleveland Clinic Innovations portfolio company focused on developing...NeuroTherapia Receives Grant from Alzheimer's Association for Development of First-in-Class Drug for Alzheimer's Disease
CLEVELAND, May 8, 2024 /PRNewswire/ -- NeuroTherapia, an early-stage clinical pharmaceutical company, announced today that it has received a grant from the Alzheimer's Association Part the Cloud program for the development of its first-in-class drug, NTRX-07, for the treatment of...NeuroTherapia Closes $8.8M Series A Financing Led By Brain Trust Accelerator Fund II
CLEVELAND, Sept. 22, 2020 /PRNewswire/ -- NeuroTherapia, Inc., a clinical-stage company focused on developing therapies for neurodegenerative diseases, announced today the closing of its Series A financing of $8.8M. The Series A round, led by Brain Trust Accelerator Fund II, included...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NeuroTherapia
Sign Up For FreeTo access detailed company insights
Founded in 2015 and headquartered in Gates Mills, Ohio, NeuroTherapia biotech company developing a novel small molecule for the treatment of neurodegenerative disorders. NTRX-07 is a small orally-available molecule that targets receptors that are known to be increased in diseases including Alzheimer's disease (AD), ALS, MS and chronic pain syndrome... Read More
